These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6779436)

  • 1. Spiramycin, a macrolide antibiotic.
    Abou-Zeid AZ; Khalil A el-G ; Rabei M
    Zentralbl Bakteriol Naturwiss; 1980; 135(5):443-53. PubMed ID: 6779436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbomycin, a macrolide antibiotic.
    Ashy MA; Khalil AE; Abou-Zeid AA
    Zentralbl Bakteriol Naturwiss; 1980; 135(6):541-51. PubMed ID: 7006261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms.
    Sadakane N; Tanaka Y; Omura S
    J Antibiot (Tokyo); 1982 Jun; 35(6):680-7. PubMed ID: 7118724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of a plasmid in Streptomyces ambofaciens KA-1028 and its possible involvement in spiramycin production.
    Omura S; Ikeda H; Kitao C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1058-60. PubMed ID: 528367
    [No Abstract]   [Full Text] [Related]  

  • 5. The microbial transformation of tylosin by the spiramycin-producing strain, Streptomyces ambofaciens KA-1028.
    Omura S; Kitao C; Sadakane N
    J Antibiot (Tokyo); 1980 Aug; 33(8):911-2. PubMed ID: 7429995
    [No Abstract]   [Full Text] [Related]  

  • 6. CV-1, a new antibiotic produced by a strain of Streptomyces sp. I. Fermentation, isolation and biological properties of the antibiotic.
    Ichimura M; Koguchi T; Yasuzawa T; Tomita F
    J Antibiot (Tokyo); 1987 Jun; 40(6):723-6. PubMed ID: 3301772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved production of spiramycin by mutant Streptomyces ambofaciens.
    Jin ZH; Cen PL
    J Zhejiang Univ Sci; 2004 Jun; 5(6):689-95. PubMed ID: 15101103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XIII. Regulation of spiramycin I 3-hydroxyl acylase formation by glucose, butyrate, and cerulenin.
    Kitao C; Ikeda H; Hamada H; Omura S
    J Antibiot (Tokyo); 1979 Jun; 32(6):593-9. PubMed ID: 468735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical features of spiramycin biosynthesis in Streptomyces ambofaciens--curing, protoplast regeneration and plasmid transfer.
    Ikeda H; Tanaka H; Omura S
    J Antibiot (Tokyo); 1982 Apr; 35(4):507-16. PubMed ID: 7096204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic.
    Fujiwara T; Watanabe H; Kogami Y; Shiritani Y; Sakakibara H
    J Antibiot (Tokyo); 1989 Jun; 42(6):903-12. PubMed ID: 2500413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of a metronidazole-spiramycin association on anaerobic bacteria].
    Videau D
    Pathol Biol (Paris); 1971; 19(11):661-6. PubMed ID: 4326560
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of a hybrid macrolide antibiotic in Streptomyces ambofaciens and Streptomyces lividans by introduction of a cloned carbomycin biosynthetic gene from Streptomyces thermotolerans.
    Epp JK; Huber ML; Turner JR; Goodson T; Schoner BE
    Gene; 1989 Dec; 85(2):293-301. PubMed ID: 2628170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete genome sequence of Streptomyces ambofaciens ATCC 23877, the spiramycin producer.
    Thibessard A; Haas D; Gerbaud C; Aigle B; Lautru S; Pernodet JL; Leblond P
    J Biotechnol; 2015 Nov; 214():117-8. PubMed ID: 26410452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a glycosyl transferase inactivating macrolides, encoded by gimA from Streptomyces ambofaciens.
    Gourmelen A; Blondelet-Rouault MH; Pernodet JL
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2612-9. PubMed ID: 9756764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diperamycin, a new antimicrobial antibiotic produced by Streptomyces griseoaurantiacus MK393-AF2. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
    Matsumoto N; Momose I; Umekita M; Kinoshita N; Chino M; Iinuma H; Sawa T; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1998 Dec; 51(12):1087-92. PubMed ID: 10048567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of spiramycin synthesis in Streptomyces ambofaciens: effects of glucose and inorganic phosphate.
    Lounès A; Lebrihi A; Benslimane C; Lefebvre G; Germain P
    Appl Microbiol Biotechnol; 1996 Mar; 45(1-2):204-11. PubMed ID: 8920193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibiotics M-4365 produced by Micromonospora. IV. Antimycoplasmal activity of antibiotic M-4365 G2 (de-epoxy rosamicin).
    Onta T; Maezawa I; Kinumaki A; Ohshima S; Yamaguchi T
    J Antibiot (Tokyo); 1981 Jun; 34(6):719-26. PubMed ID: 7275854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid catabolism and antibiotic synthesis: valine is a source of precursors for macrolide biosynthesis in Streptomyces ambofaciens and Streptomyces fradiae.
    Tang L; Zhang YX; Hutchinson CR
    J Bacteriol; 1994 Oct; 176(19):6107-19. PubMed ID: 7928973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucose limitation on biomass and spiramycin production by Streptomyces ambofaciens.
    Colombié V; Bideaux C; Goma G; Uribelarrea JL
    Bioprocess Biosyst Eng; 2005 Nov; 28(1):55-61. PubMed ID: 16195896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.